158 related articles for article (PubMed ID: 32419081)
1. Polymorphisms of the genes CTLA4, PTPN22, CD40, and PPARG and their roles in Graves' disease: susceptibility and clinical features.
Bufalo NE; Dos Santos RB; Rocha AG; Teodoro L; Romaldini JH; Ward LS
Endocrine; 2021 Jan; 71(1):104-112. PubMed ID: 32419081
[TBL] [Abstract][Full Text] [Related]
2. Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies.
Inoue N; Watanabe M; Yamada H; Takemura K; Hayashi F; Yamakawa N; Akahane M; Shimizuishi Y; Hidaka Y; Iwatani Y
J Clin Immunol; 2012 Dec; 32(6):1243-52. PubMed ID: 22706687
[TBL] [Abstract][Full Text] [Related]
3. Correlation between CTLA-4 and CD40 gene polymorphisms and their interaction in graves' disease in a Chinese Han population.
Chen X; Hu Z; Liu M; Li H; Liang C; Li W; Bao L; Chen M; Wu G
BMC Med Genet; 2018 Sep; 19(1):171. PubMed ID: 30223781
[TBL] [Abstract][Full Text] [Related]
4. Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.
Ichimura M; Kaku H; Fukutani T; Koga H; Mukai T; Miyake I; Yamada K; Koda Y; Hiromatsu Y
Thyroid; 2008 Jun; 18(6):625-30. PubMed ID: 18578611
[TBL] [Abstract][Full Text] [Related]
5. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.
Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ
Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904
[TBL] [Abstract][Full Text] [Related]
6. Genetic variant association of PTPN22, CTLA4, IL2RA, as well as HLA frequencies in susceptibility to alopecia areata.
Moravvej H; Tabatabaei-Panah PS; Abgoon R; Khaksar L; Sokhandan M; Tarshaei S; Ghaderian SMH; Ludwig RJ; Akbarzadeh R
Immunol Invest; 2018 Oct; 47(7):666-679. PubMed ID: 29979892
[TBL] [Abstract][Full Text] [Related]
7. Synergistic combined effect between CD40-1C>T and CTLA-4+6230G>A polymorphisms in Graves' disease.
Chen X; Hu Z; Li W; Wu P; Liu M; Bao L; Wu M; Fang S; Xiong W; Chen M; Wu G
Gene; 2015 Aug; 567(2):154-8. PubMed ID: 25936345
[TBL] [Abstract][Full Text] [Related]
8. Identification of susceptibility SNPs in CTLA-4 and PTPN22 for scleritis in Han Chinese.
Li F; Ma X; Du L; Shi L; Cao Q; Li N; Pang T; Liu Y; Kijlstra A; Yang P
Clin Exp Immunol; 2019 Aug; 197(2):230-236. PubMed ID: 30921471
[TBL] [Abstract][Full Text] [Related]
9. Association of PTPN22 polymorphism and its correlation with Graves' disease susceptibility in Polish adult population-A preliminary study.
Wawrusiewicz-Kurylonek N; Koper-Lenkiewicz OM; Gościk J; Myśliwiec J; Pawłowski P; Krętowski AJ
Mol Genet Genomic Med; 2019 Jun; 7(6):e661. PubMed ID: 30938100
[TBL] [Abstract][Full Text] [Related]
10. Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset.
Steiner S; Becker SC; Hartwig J; Sotzny F; Lorenz S; Bauer S; Löbel M; Stittrich AB; Grabowski P; Scheibenbogen C
Front Immunol; 2020; 11():578. PubMed ID: 32328064
[TBL] [Abstract][Full Text] [Related]
11. Associations of single nucleotide polymorphisms of PTPN22 and Ctla4 genes with the risk of allergic rhinitis in a Chinese Han population.
Ke X; Song S; Wang X; Shen Y; Kang H; Hong S
Hum Immunol; 2017 Feb; 78(2):227-231. PubMed ID: 27888068
[TBL] [Abstract][Full Text] [Related]
12. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
Skórka A; Bednarczuk T; Bar-Andziak E; Nauman J; Ploski R
Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
[TBL] [Abstract][Full Text] [Related]
13. PTPN22 and CTLA-4 Polymorphisms Are Associated With Polyglandular Autoimmunity.
Houcken J; Degenhart C; Bender K; König J; Frommer L; Kahaly GJ
J Clin Endocrinol Metab; 2018 May; 103(5):1977-1984. PubMed ID: 29409002
[TBL] [Abstract][Full Text] [Related]
14. The PTPN22 R263Q polymorphism confers protection against systemic lupus erythematosus and rheumatoid arthritis, while PTPN22 R620W confers susceptibility to Graves' disease in a Mexican population.
López-Cano DJ; Cadena-Sandoval D; Beltrán-Ramírez O; Barbosa-Cobos RE; Sánchez-Muñoz F; Amezcua-Guerra LM; Juárez-Vicuña Y; Aguilera-Cartas MC; Moreno J; Bautista-Olvera J; Valencia-Pacheco G; López-Villanueva RF; Ramírez-Bello J
Inflamm Res; 2017 Sep; 66(9):775-781. PubMed ID: 28500376
[TBL] [Abstract][Full Text] [Related]
15. Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis.
Carr EJ; Niederer HA; Williams J; Harper L; Watts RA; Lyons PA; Smith KG
BMC Med Genet; 2009 Dec; 10():121. PubMed ID: 19951419
[TBL] [Abstract][Full Text] [Related]
16. Association analysis of PTPN22, CTLA4 and IFIH1 genes with type 1 diabetes in Colombian families.
Rodríguez A; Alfaro JM; Balthazar V; Pineda Trujillo N
J Diabetes; 2015 May; 7(3):402-10. PubMed ID: 25042601
[TBL] [Abstract][Full Text] [Related]
17. [Association of polymorphism of protein tyrosine phosphatase nonreceptor-22 gene with AITD].
Yu ZY; Zhang JA; Maier HB; Wang Y; Xiao WX; Quan Y; Dong BN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Aug; 24(8):804-7. PubMed ID: 18687223
[TBL] [Abstract][Full Text] [Related]
18. CD40 C/T(-1) and CTLA-4 A/G(49) SNPs are associated with autoimmune thyroid diseases in the Chinese population.
Yang J; Qin Q; Yan N; Zhu YF; Li C; Yang XJ; Wang X; Pandey M; Hou P; Zhang JA
Endocrine; 2012 Feb; 41(1):111-5. PubMed ID: 21866398
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort.
Bank S; Skytt Andersen P; Burisch J; Pedersen N; Roug S; Galsgaard J; Ydegaard Turino S; Brodersen JB; Rashid S; Kaiser Rasmussen B; Avlund S; Bastholm Olesen T; Jürgen Hoffmann H; Kragh Thomsen M; Ostergaard Thomsen V; Frydenberg M; Andersen Nexø B; Sode J; Vogel U; Andersen V
PLoS One; 2014; 9(6):e98815. PubMed ID: 24971461
[TBL] [Abstract][Full Text] [Related]
20. Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.
Karlson EW; Chibnik LB; Cui J; Plenge RM; Glass RJ; Maher NE; Parker A; Roubenoff R; Izmailova E; Coblyn JS; Weinblatt ME; Shadick NA
Ann Rheum Dis; 2008 Mar; 67(3):358-63. PubMed ID: 17666451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
